GxP
The Role of the EMA in Vaccine Approvals
In response to the COVID-19 pandemic, the European Medicines Agency (EMA) adapted its vaccine approval processes, implementing rolling reviews and enhancing collaboration with health authorities. This post analyzes the EMA’s pivotal role in granting conditional marketing authorizations for COVID-19 vaccines and discusses the implications for future vaccine regulation and public health strategies. Learn how transparency, accelerated approval processes, and increased patient engagement are shaping the future of vaccine delivery in Europe.
April 7, 2025
